Move allows greater focus on Mainstreet and company’s new product offerings
CARMEL, Ind., Sept. 19, 2017 /CNW/ — Zeke Turner, founder and CEO of Mainstreet, announced today that he is stepping down from the board of directors of Mainstreet Health Investments, Inc. (TSX:HLP.U) inclusive of his position of Chairman of the Board, a position he has held since June 2016. Turner’s resignation from his board position is effective immediately.
Turner cited the growth of Carmel-based Mainstreet as a key motivation for his decision. Mainstreet is a national company specializing in real estate development, value investments, and health care operations. Founded by Turner in 2002, the company announced last week that it will open four post-acute healthcare properties in Arizona, with five additional properties to follow in Texas. Rapid Recovery from Mainstreet Health® (RRC) specializes in rehabilitation and care immediately following a hospital stay.
“I’m proud of what we have accomplished with Mainstreet Health Investments,” said Turner, “but now is the right time for me to focus my efforts on Mainstreet’s continued growth in both our real estate development business and our innovative healthcare operations. Our new RRC properties position us to be leaders in the post-acute care field, where we will bridge a vital gap in rehabilitation treatment that results in better outcomes for patients, hospitals and physicians. It’s an exciting time for our company, and I’m looking forward to our continued push to transform the lives of the people we serve.”
Mainstreet is a company focused on transforming lives through real estate development, value investments and health care operations. As one of the nation’s premier developers of post-acute health care properties, Mainstreet has been recognized by Senior Housing News, winning the Architecture & Design Award in 2013, 2014 and 2015, and has been named to the Inc. 500l5000 seven times since 2010.
View original content: http://www.newswire.ca/en/releases/archive/September2017/19/c4153.html